Answers are grounded in this paper and cite their sources.
Introduction. Ovarian Insufficiency, characterized by a premature loss of ovarian function, presents a significant challenge for women, with limited effective treatments available. While widely used in other medical fields, platelet-rich plasma (PRP) therapy has recently emerged as a promising approach, offering potential for ovarian rejuvenation and improved fertility outcomes. The aim of the study. To develop a greater understanding of platelet-rich plasma therapy-enhanced ovarian rejuvenation as a promising approach towards ovarian insufficiency and fertility preservation. Materials and methods. An extensive review was conducted using PubMed, ScienceDirect, and Google Scholar databases, focusing on studies published between 2019 and 2024. Studies investigating PRP therapy for ovarian insufficiency and infertility in both human and animal models were analyzed to assess the mechanisms, efficacy, and safety profile. Results. PRP therapy enhances ovarian repair by increasing blood flow to ovarian tissue, inhibiting apoptosis of granulosa cells, and promoting cellular repair to restore hormonal balance. It is associated with increased (anti-mullerian hormone), decreased (follicle stimulating hormone), and higher antral follicular counts. PRP alleviates menopausal symptoms, restores regular menstrual cycles and improves embryo quality in in vitro fertilization. Animal models further support PRP’s role in ovarian tissue repair. Additionally, its use in polycystic ovarian syndrom, endometriosis, and intrauterine adhesions are under investigation. Conclusions. Overall, platelet-rich plasma therapy is a breakthrough in reproductive medicine for treating ovarian insufficiency, recurrent implantation failure, and menopausal symptoms, offering a non-invasive, cost-effective alternative with regenerative properties. While promising, optimal dosage, safety profile, and long-term health implications remain unclear. Large scale trials and follow-up studies post pregnancy are needed to standardize platelet-rich plasma use protocols. If standardized, platelet-rich plasma could play a vital role in fertility treatments for women in the future, potentially transforming the landscape of reproductive medicine.
No takes yet. Share an insight, caveat, or question.
Sakina et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: